A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy
Authors:
Top Cited Papers
- 11 May 2024
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 36 (30) , e2403253
Abstract
Low efficacy of immunotherapy due to the poor immunogenicity of most tumors and their insufficient infiltration by immune cells highlights the importance of inducing immunogenic cell death and activating immune system for achieving better treatment outcomes. Herein, ferroelectric Bi2CuO4 nanoparticles with rich copper vacancies (named BCO‐VCu) are rationally designed and engineered for ferroelectricity‐enhanced apoptosis, cuproptosis, and the subsequently evoked immunotherapy. In this structure, the suppressed recombination of the electron–hole pairs by the vacancies and the band bending by the ferroelectric polarization lead to high catalytic activity, triggering reactive oxygen species bursts and inducing apoptosis. The cell fragments produced by apoptosis serve as antigens to activate T cells. Moreover, due to the generated charge by the ferroelectric catalysis, this nanomedicine can act as “a smart switch” to open the cell membrane, promote nanomaterial endocytosis, and shut down the Cu+ outflow pathway to evoke cuproptosis, and thus a strong immune response is triggered by the reduced content of adenosine triphosphate. Ribonucleic acid transcription tests reveal the pathways related to immune response activation. Thus, this study firstly demonstrates a feasible strategy for enhancing the efficacy of immunotherapy using single ferroelectric semiconductor‐induced apoptosis and cuproptosis.Keywords
Funding Information
- National Natural Science Foundation of China (22275045, 52272144, 51972076, U22A20347)
- Natural Science Foundation of Heilongjiang Province (JQ2023B001, JQ2022E001, ZD2019E004)
- Natural Science Foundation of Shandong Province (ZR2019ZD29)
This publication has 66 references indexed in Scilit:
- Low‐Dose Cu Ions Assisted by Mild Thermal Stimulus Inducing Bacterial Cuproptosis‐Like Death for Antibiosis and BiointegrationAdvanced Functional Materials, 2023
- A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid TumorsAdvanced Materials, 2022
- An NIR‐II Photothermally Triggered “Oxygen Bomb” for Hypoxic Tumor Programmed Cascade TherapyAdvanced Materials, 2022
- A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and ImmunotherapyAdvanced Functional Materials, 2022
- 2D Piezoelectric Bi2MoO6 Nanoribbons for GSH‐Enhanced Sonodynamic TherapyAdvanced Materials, 2021
- Second Near‐Infrared Light‐Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer TherapyAdvanced Materials, 2021
- Highly Efficient Far‐Red/NIR‐Absorbing Neutral Ir(III) Complex Micelles for Potent Photodynamic/Photothermal TherapyAdvanced Materials, 2021
- Customized Photothermal Therapy of Subcutaneous Orthotopic Cancer by Multichannel Luminescent NanocompositesAdvanced Materials, 2021
- Recent Advances in Hyperthermia Therapy‐Based Synergistic ImmunotherapyAdvanced Materials, 2020
- Monodisperse and Uniform Mesoporous Silicate Nanosensitizers Achieve Low‐Dose X‐Ray‐Induced Deep‐Penetrating Photodynamic TherapyAdvanced Materials, 2019